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Summary. Blood–brain penetration of 20-hydroxyecdysone 2,3;20,22-diacetonide (20DA) 
has been scouted using chromatographic methods. In vivo experiments were performed 
by treating male Wistar rats intraperitoneally (i.p.) with a dose of 50 mg kg−1 20DA. 
Control experiment was done by using 20-hydroxyecdysone (20E). Definite brain 
penetration of 20DA was found by using high-performance liquid chromatography 
(HPLC), while 20E does not show this type of distribution. 
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Introduction 
 
The first ecdysteroids (α-ecdysone and 20E) were isolated by Butenandt and 
Karlson in 1954 [1]. Physiologically, they principally functioned as insect-
molting hormones. Compared to insects, plants contain a wider variety and 
higher levels of ecdysteroids. Specialists of ecdysteroid research declared an 
interesting spectrum of effects of ecdysteroids on mammalian organisms, 
such as, for example, the ability of these compounds to improve protein 
incorporation. Báthori [2], Dinan and Lafont [3], and Dinan [4] published in-
depth reviews on the effects and applications of ecdysteroids. Lafont et al. 
[5] summarized the excretion and metabolism of ecdysone injected into 
white mice. The practical uses of ecdysteroids (including humans) have 
been critically reviewed by Lafont and Dinan [6]. Nevertheless, only a few 
publications have been dealing with any interaction of ecdysteroids and the 
central nervous system [7, 8]. Lipophilic substituents on hydroxyl(s) are 
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supposed to change both their hydrophilic/hydrophobic character and their 
distribution in the mammalian central nervous system. The structure of 
natural ecdysteroids is generally characterized as a hydroxylated steroid 
skeleton with 7-ene-6-one conjugation. As such, they have a highly 
hydrophilic nature. Lipophilicity of several ecdysteroids was determined 
using reversed-phase thin-layer chromatography, giving in the order of 
decreasing RM values such as cyasterone, 22-deoxy-20-hydroxyecdysone,   
2-deoxyecdysone, viticosterone E, makisterone A, 22-deoxy-20-hydroxyec-
dysone, 20-hydroxyecdysone 22 acetate, rubrosterone, polypodine B,         
20-hydroxyecdysone, and integristerone A [9]. Martins et al. described that 
less polar ecdysteroid derivatives, in particularly those with substituted 
dioxolane rings at positions 2,3 and 20,22 like, for example, diacetonides, 
can exert a strong chemo-sensitizing activity on various cancer cell lines 
including drug-sensitive as well as multidrug-resistant ones [10–12]. In a 
most recent study by Müller et al. (Eur. J. Pharm. Sci., manuscript under 
revision) employing a combination of in silico and in vitro techniques, 20DA 
was identified as a prospective chemosensitizer lead compound against 
central nervous system tumors. 
This paper presents how diacetonide substitution changes the in vivo 
distribution of 20E in rats 15 min after an intraperitoneal (i.p.) treatment. 
 
 
Experimental 
 
Materials and Methods 
 
Chemicals 
 
Formic acid 85%, water HiPerSolv ChromaNorm LC–MS grade, and 
methanol HiPerSolv ChromaNorm LC–MS grade were purchased from 
VWR International Kft, Debrecen, Hungary. Acetonitrile, HPLC grade, was 
bought from Sigma-Aldrich Kft., Budapest, Hungary.  
 
 
 
 
 
 
 
 
Fig. 1. The chemical structure of 20-hydroxyecdysone 2,3;20,22-diacetonide 
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20DA (Fig. 1) was prepared as published by Balázs et al. [13]. 20E was 
isolated previously from the plant Serratula wolffii Andrae [14]. 
 
 
Animals and treatment 
 
Male Wistar rats weighing 200 ± 1.6 g were purchased from Toxicoop 
(Budapest, Hungary). The experiments conformed to 86/509/EEC 
regulation on the well-being of experimental animals. The experimental 
protocol has the permission number: 1810/003/2004 ANTSZ, Budapest. 
Animals' treatment 
Rats (three groups, n = 2, in each group) were (1) controls, treated with 
water, sacrificed after 15 min; (2) treated with 20E, sacrificed after 15 min; 
and (3) treated with 20DA, sacrificed after 15 min. 
Treatment was done by an i.p. injection of 0.2 mL of 250 mg mL−1 of 
either 20DA or 20E, freshly dissolved in double-distilled water. This way, 
the resulting dose was 50 mg 20E or 20DA per kilogram of the animal body 
weight. Following the 15 min of treatment, diethylether-anesthetized rats 
were exsanguinated through the canthus and cerebrospinal fluid (CSF) was 
withdrawn by cisternal punction. Brains and liver were dissected and 
placed on a 0 °C aluminum surface. The tissue samples were stored at      
−80 °C until analysis.  
 
 
Preparation of biological samples for analysis 
 
Dissected brain and liver tissues from both untreated or treated animals 
were homogenized in a 4× w/v amount of acetonitrile using an Ultra Turrax 
T25 (Janke & Kunkel homogenizer IKA Labortechnik, Staufen, Germany) at 
20,000 rpm for 30 s at room temperature. The homogenates were centri-
fuged in an Eppendorf centrifuge (A. Hettich, Tuttlingen, Germany) with 
14,000 rpm for 20 min at 4 °C. The supernatants were collected for analysis. 
Serum and CSF samples (200 μL) were mixed with 800 μL methanol 
and vortexed for 1 min, followed by centrifugation at 13,500 rpm for 5 min. 
The 100-μL aliquots of supernatant were diluted with 100 μL water and 
submitted for quantitative analysis as such (20DA treatment) or evaporated 
under N2 stream and redissolved in 20% aqueous acetonitrile prior to 
testing (20E treatment). 
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Quantitative determination by high-performance liquid chromatograph 
connected to diode-array detector (HPLC–DAD) 
 
A Jasco HPLC–DAD gradient system (Jasco Co., Tokyo, Japan, purchased 
from ABL&E Jasco, Budapest, Hungary) was utilized with a Kinetex XB-C18 
(5 μm, 4.6 × 250 mm; Phenomenex, Torrance, CA, USA) analytical column 
and isocratic solvent systems of 20% (20E) or 80% aqueous acetonitrile 
(20DA) at a flow rate of 1 mL min−1. 20E and 20DA were dissolved in 20 and 
80% aqueous acetonitrile, respectively, at concentrations of 1.00 mg mL−1.    
 
 
Fig. 2. An eight-point calibration curve for the determination of 20-hydroxyecdysone 
2,3;20,22-diacetonide 
 
 
Fig. 3. An eight-point calibration curve for the determination of 20-hydroxyecdysone 
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A 100-fold dilution of each (10 μg mL−1) with a respective solvent was 
utilized as stock solution, which served as a basis for further dilutions. An 
eight-point calibration was performed for 20DA from standard solutions of 
0.5, 0.67, 1.0, 1.43, 2.0, 5.0, 10.0 and 20.0 μg mL−1 (Fig. 2). For 20E, an eight-
point calibration was performed from standard solutions representing 0.5, 
0.67, 0.83, 1.0, 1.43, 2.0, 5.0, and 10.0 μg mL−1 concentrations (Fig. 3). In each 
case, 10-μL volumes were injected in triplicates, and manual integration was 
applied at λ = 254 nm.  
 
 
Results and Discussion 
 
The results of the HPLC analysis of 20DA and 20E are shown in Figs. 4–6. 
The HPLC analysis of 20DA shows an almost 5 μg mL−1 level of this 
compound in the serum of rats 15 min after the i.p. administration (Table I). 
The serum level corresponds to almost 40% 20DA getting into circulation, 
while 10% of the circulating 20DA level penetrated into the brain. 
Elimination of 20DA apparently takes place mainly through the liver, where 
its level is approximately seven times higher than in the serum. The HPLC 
analysis of 20E in the circulation revealed its levels by one magnitude order 
lower than those of 20DA, and the brain level of 20E was under the limit of 
detection (<LOD). 
20DA shows much higher lipophilicity than either polypodine B or 20E 
(not shown here). Its consequence is a much higher absorption and 
distribution in rats. 
 
Table I. 20DA and 20E levels in various organs and body fluids of  
rats following 15 min of i.p. injection 
Sample 20DA level  (mean) 
20DA relative  
to serum  
(%) 
20E level  
(mean) 
Serum 4.45 μg mL-1 100.00 0.50 µg mL-1 
Brain (right) 0.45 μg g-1 10.11 <LOD 
CSF 0.23 μg mL-1 5.17 <LOD 
Liver 27.99 μg g-1 628.98 0.81 μg g-1 
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Fig. 4. HPLC chromatograms of plasma samples for the analysis of 20-hydroxyecdysone 
2,3;20,22-diacetonide on a Kinetex XB-C18 (4.6 × 250 mm, 5 μm) column.  
Top chromatogram plasma from untreated animals, bottom chromatogram:  
plasma from animals treated with 20DA 
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Fig. 5. The HPLC–DAD spectrochromatograms of liver samples for the analysis of 
 20-hydroxyecdysone 2,3;20,22-diacetonide on a Kinetex XB-C18 (4.6 × 250 mm, 5 μm) 
column. Top spectrochromatogram: liver sample from untreated animals; bottom 
spectrochromatogram: liver sample from animals treated with 20DA 
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Fig. 6. HPLC chromatograms of brain samples for the analysis of 20-hydroxyecdysone 
2,3;20,22-diacetonide on a Kinetex XB-C18 (4.6 × 250 mm, 5 μm) column.  
Top chromatogram: brain sample from untreated animals; bottom chromatogram: brain 
sample from animals treated with 20DA 
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